German biotech continues to grow, representing an opportunity for foreign capital.
Industries / Life Sciences
New foreign investors in German biotech star BioNTech are expecting big breakthroughs in cancer therapies through the development of individually-tailored vaccines; rapid growth is anticipated.
Telemedicine is making further inroads into the German healthcare system, which could enjoy annual savings of EUR 5.6 billion as a result.
Harnessing the power of plasma.
New production process will save lives.
The German healthcare system is one step closer to the introduction of electronic patient files – and the myriad benefits they will offer.
Uniklinik Essen, one of Germany’s university hospitals, is introducing a wide range of technology and processes that use artificial intelligence to improve healthcare and advance it on the path to becoming a “smart” digitalized hospital.
Are you looking for information about the healthcare market in Germany? Access conditions, market data, sales opportunities and trends? Talk to the experts of GTAI at the MEDICA 2018, booth F37, hall 15.
German companies, researchers and developers are pioneering the disruptive AI applications of the future.Little wonder foreign investment is flowing into German R&D.
The Chinese startup Infervision is hoping to transform the healthcare market all over Europe and prove that thinking machines can save lives.